Tom Schulz
Dortmund, NW 44227, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Lessons from Structural Biology for Understanding Drug Resistance in Gastrointestinal Stromal Tumors (GIST).
Journal: Journal of medicinal chemistry
Published: March 02, 2026
Energy Spectrum of Ultrahigh-Energy Cosmic Rays across Declinations -90° to +44.8° as Measured at the Pierre Auger Observatory.
Journal: Physical review letters
Published: June 16, 2025
Phase II Trial of Ponatinib in Patients with Metastatic Gastrointestinal Stromal Tumor following Failure or Intolerance of Prior Therapy with Imatinib (POETIG Trial).
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 24, 2025
Design, Synthesis, and SAR of Covalent KIT and PDGFRA Inhibitors─Exploring Their Potential in Targeting GIST.
Journal: Journal of medicinal chemistry
Published: January 22, 2025
Advancing TET Inhibitor Development: From Structural Insights to Biological Evaluation.
Journal: ACS medicinal chemistry letters
Published: January 22, 2025
KIT ATP-Binding Pocket/Activation Loop Mutations in GI Stromal Tumor: Emerging Mechanisms of Kinase Inhibitor Escape.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 26, 2024
Addressing the Osimertinib Resistance Mutation EGFR-L858R/C797S with Reversible Aminopyrimidines.
Journal: ACS medicinal chemistry letters
Published: December 08, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026